{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:02:26Z","timestamp":1791918146950,"version":"4.3.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Cardio Med"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1007\/s11936-006-0023-9","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T09:40:07Z","timestamp":1180863607000},"page":"23-35","source":"Crossref","is-referenced-by-count":9,"title":["Selection of optimal therapy for chronic stable angina"],"prefix":"10.1007","volume":"8","author":[{"given":"Udho","family":"Thadani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"23_CR1","unstructured":"Thadani U: Chronic stable angina pectoris. In Cardiology. Edited by Crawford MH, et al. Mosby; 2004:257\u2013270."},{"issue":"suppl 1","key":"23_CR2","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1177\/107424840400900103","volume":"9","author":"U Thadani","year":"2004","unstructured":"Thadani U: Current medical management of chronic stable angina. J Cardiovasc Pharmacol Ther 2004, 9(suppl 1):S11-S29. A recent review article that provides comprehensive current management of chronic stable angina with references.","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"23_CR3","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1161\/CIRCULATIONAHA.104.526699","volume":"112","author":"J Abrams","year":"2005","unstructured":"Abrams J, Thadani U: Therapy of stable angina pectoris: the uncomplicated patient. Circulation 2005, 112:e255-e259.","journal-title":"Circulation"},{"issue":"suppl 1","key":"23_CR4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00129784-200303001-00002","volume":"3","author":"U Thadani","year":"2003","unstructured":"Thadani U: The pursuit of optimum outcomes in stable angina. Am J Cardiovasc Drugs 2003, 3(suppl 1):11\u201320.","journal-title":"Am J Cardiovasc Drugs"},{"key":"23_CR5","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/01.CIR.73.5.865","volume":"73","author":"JE Gage","year":"1986","unstructured":"Gage JE, Jess DM, Murakami T, et al.: Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin. Circulation 1986, 73:865\u2013871.","journal-title":"Circulation"},{"key":"23_CR6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/hrt.53.4.363","volume":"53","author":"MJ Davies","year":"1985","unstructured":"Davies MJ, Thomas AC: Plaque fissuring: the cause of acute myocardial infarction, sudden ischemic death, and crescendo angina. Br Heart J 1985, 53:363\u2013368.","journal-title":"Br Heart J"},{"key":"23_CR7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0733-8651(18)30315-1","volume":"9","author":"TC Hinton","year":"1991","unstructured":"Hinton TC, Chaitman BR: The prognosis in stable and unstable angina. Cardiol Clin 1991, 9:27\u201338.","journal-title":"Cardiol Clin"},{"key":"23_CR8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0002-9149(97)00382-2","volume":"79","author":"U Thadani","year":"1997","unstructured":"Thadani U: Management of patients with chronic stable angina at low risk for serious cardiac events. Am J Cardiol 1997, 79:24\u201330.","journal-title":"Am J Cardiol"},{"key":"23_CR9","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1056\/NEJM199109193251204","volume":"325","author":"DB Mark","year":"1991","unstructured":"Mark DB, Shaw L, Harrell GE, et al.: Prognostic value of a treadmill exercise score in outpatients with suspected coronary disease. N Eng J Med 1991, 325:849\u2013853.","journal-title":"N Eng J Med"},{"key":"23_CR10","first-page":"143","volume":"107","author":"RJ Gibbons","year":"2003","unstructured":"Gibbons RJ, Abrams J, Chatterjee K, et al.: ACC\/AHA\/ ACP-ASIM Guideline update for the management of patients with chronic stable angina: summary and abstract. Circulation 2003, 107:143\u2013158.","journal-title":"Circulation"},{"key":"23_CR11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00001573-199907000-00011","volume":"14","author":"U Thadani","year":"1999","unstructured":"Thadani U: Management of stable angina pectoris. Curr Opin Cardiol 1999, 14:349\u2013358.","journal-title":"Curr Opin Cardiol"},{"key":"23_CR12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2165\/00002018-199819010-00003","volume":"19","author":"S Asirvatham","year":"1998","unstructured":"Asirvatham S, Sebastian C, Thadani U: Choosing the most appropriate treatment for stable angina: safety considerations. Drug Saf 1998, 19:23\u201344.","journal-title":"Drug Saf"},{"key":"23_CR13","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1001\/jama.281.20.1927","volume":"281","author":"PA Heidenreich","year":"1999","unstructured":"Heidenreich PA, McDonald KM, Hastie T, et al.: Metaanalysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina. JAMA 1999, 281:1927\u20131936.","journal-title":"JAMA"},{"key":"23_CR14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10557-005-5056-x","volume":"18","author":"U Thadani","year":"2004","unstructured":"Thadani U: Prevention of nitrate tolerance with angiotensin II receptor type 1 blocker in patients with stable angina: yet another failed strategy to prevent tolerance. Cardiovasc Drugs Ther 2004, 18:339\u2013342.","journal-title":"Cardiovasc Drugs Ther"},{"key":"23_CR15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0033-0620(96)80014-4","volume":"38","author":"LH Opie","year":"1996","unstructured":"Opie LH: Calcium channel antagonists in the treatment of coronary artery disease: fundamental pharmacological properties relevant to clinical use. Prog Cardiovasc Dis 1996, 38:273\u2013290.","journal-title":"Prog Cardiovasc Dis"},{"key":"23_CR16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1067\/mhj.2002.122876","volume":"144","author":"U Thadani","year":"2002","unstructured":"Thadani U: Selective L-type, and non-selective calcium channel blockers for stable angina pectoris [editorial]. Am Heart J 2002, 144:8\u201310.","journal-title":"Am Heart J"},{"key":"23_CR17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/oxfordjournals.eurheartj.a014695","volume":"17","author":"N Rehnquist","year":"1996","unstructured":"Rehnquist N, Hjemdahl P, Billing E, et al.: Effect of metoprolol versus verapamil in patients with stable angina pectoris. The angina prognosis study in Stockholm (APSIS). Eur Heart J 1996, 17:76\u201381.","journal-title":"Eur Heart J"},{"key":"23_CR18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/oxfordjournals.eurheartj.a014668","volume":"17","author":"HJ Dargie","year":"1996","unstructured":"Dargie HJ, Ford I, Fox KM: Effects of ischemia and treatment with atenolol, nifedipine SR and their combination on outcomes in patient with chronic stable angina. Eur Heart J 1996, 17:104\u2013112.","journal-title":"Eur Heart J"},{"key":"23_CR19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0002-9149(97)00877-1","volume":"81","author":"P Dunselman","year":"1998","unstructured":"Dunselman P, van Kempen L, Bouwens L, et al.: Value of the addition of amlodipine to atenolol in patients with angina pectoris despite adequate beta blockade. Am J Cardiol 1998, 81:128\u2013132.","journal-title":"Am J Cardiol"},{"key":"23_CR20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0002-9149(97)00893-X","volume":"81","author":"C Knight","year":"1998","unstructured":"Knight C, Fox K: Amlodipine versus diltiazem as additional antianginal treatment to atenolol. Am J Cardiol 1998, 81:133\u2013136.","journal-title":"Am J Cardiol"},{"key":"23_CR21","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/0140-6736(91)91900-F","volume":"338","author":"F Akhras","year":"1991","unstructured":"Akhras F, Jackson A: Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina. Lancet 1991, 338:1036\u20131039.","journal-title":"Lancet"},{"key":"23_CR22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0002-9149(97)00382-2","volume":"6","author":"U Thadani","year":"1997","unstructured":"Thadani U: Combination therapy. Am Coll Cardiol Curr J Rev 1997, 6:24\u201325.","journal-title":"Am Coll Cardiol Curr J Rev"},{"key":"23_CR23","doi-asserted-by":"crossref","first-page":"570","DOI":"10.7326\/0003-4819-109-7-570","volume":"109","author":"WE Strauss","year":"1988","unstructured":"Strauss WE, Parisi AF: Combined use of calcium channel and beta blockers for the treatment of stable angina, rationale, efficacy and adverse events. Ann Intern Med 1988, 109:570\u2013575.","journal-title":"Ann Intern Med"},{"key":"23_CR24","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0735-1097(84)80366-6","volume":"4","author":"M Tolins","year":"1984","unstructured":"Tolins M, Weir EK, Chesler E, Pierpont GL: Maximal drug therapy is not necessarily optimal in chronic angina pectoris. Am Coll Cardiol 1984, 4:1051\u20131057.","journal-title":"Am Coll Cardiol"},{"key":"23_CR25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00045391-200501000-00006","volume":"12","author":"EI Chavoz","year":"2005","unstructured":"Chavoz EI, Lepakchin VK, Zharova EA, et al.: Trimetazidine in angina combination therapy\u2014the TACT study: trimetazidine versus conventional treatment in patients with stable angina pectoris in a randomized, placebo controlled, multicenter study. Am J Ther 2005, 12:35\u201342. A well-designed study showing that trimetazidine exerts antianginal and anti-ischemic effects when added to other antianginal drugs.","journal-title":"Am J Ther"},{"key":"23_CR26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2165\/00129784-200505050-00006","volume":"5","author":"U Thadani","year":"2005","unstructured":"Thadani U: Modified release formulation of trimetazidine for exceptional control of angina pectoris: fact or fiction. Am J Cardiovasc Drugs 2005, 5:331\u2013334.","journal-title":"Am J Cardiovasc Drugs"},{"key":"23_CR27","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jacc.2003.11.045","volume":"43","author":"BR Chaitman","year":"2004","unstructured":"Chaitman BR, Skettino SL, Parker JO: Anti-ischemic and long term survival during ranolazine monotherapy in patients with severe chronic stable angina. J Am Coll Cardiol 2004, 43:1375\u20131382. A well-designed, large, placebo-controlled trial showing that ranolazine is an effective antianginal and anti-ischemic agent.","journal-title":"J Am Coll Cardiol"},{"key":"23_CR28","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.291.3.309","volume":"291","author":"BR Chaitman","year":"2004","unstructured":"Chaitman BR, Pepine J, Parker JO: Effects of ranolazine with atenolol, amlodipine or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina. JAMA 2004, 291:309\u2013316.","journal-title":"JAMA"},{"key":"23_CR29","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(02)08265-X","volume":"359","author":"The IONA Study group","year":"2002","unstructured":"The IONA Study group: Effect of nicorandil on coronary events in patients with stable angina: the impact of nicorandil in angina (IONA) randomized trial. Lancet 2002, 359:1269\u20131275.","journal-title":"Lancet"},{"key":"23_CR30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/ncpcardio0159","volume":"2","author":"U Thadani","year":"2005","unstructured":"Thadani U: Can nicorandil effectively treat angina? Nat Clin Pract Cardiovasc Med 2005, 2:186\u2013187.","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"23_CR31","first-page":"2043","volume":"42","author":"CJ Pepine","year":"2003","unstructured":"Pepine CJ, Rouleau JL, Annis K, et al.: Effect of angiotensin converting enzyme inhibitor on transient ischemia: the Quinapril anti-ischemia and symptoms of angina reduction (QUASAR) trial. J Am Coll Cardiol 2003, 42:2043\u20132059. A large placebo-controlled trial refutes previously published data that ACE inhibitors exert antianginal and anti-ischemic effects.","journal-title":"J Am Coll Cardiol"},{"key":"23_CR32","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1136\/bmj.2.6051.1525","volume":"2","author":"R Doll","year":"1976","unstructured":"Doll R, Peto R: Mortality in relation to smoking: 20-year observations on British doctors. BMJ 1976, 2:1526\u20131536.","journal-title":"BMJ"},{"key":"23_CR33","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/0140-6736(92)92619-Q","volume":"340","author":"S Juul-Moller","year":"1992","unstructured":"Juul-Moller S, Edvardson N, Jahnmatz B, et al.: Double blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. Lancet 1992, 340:1421\u20131425.","journal-title":"Lancet"},{"key":"23_CR34","first-page":"2669","volume":"270","author":"Food and Drug Administration","year":"1993","unstructured":"Food and Drug Administration: Acetylsalicylic acid and the heart. JAMA 1993, 270:2669.","journal-title":"JAMA"},{"key":"23_CR35","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","volume":"345","author":"S Yusuf","year":"2001","unstructured":"Yusuf S, Zhao F, Mehta SR, et al.: Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001, 345:494\u2013502.","journal-title":"N Engl J Med"},{"key":"23_CR36","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, et al.: The seventh report of the joint national committee on prevention, detection,evaluation, and treatment of high blood pressure. The JNC 7 Report. JAMA 2003, 289:2560\u20132572.","journal-title":"JAMA"},{"key":"23_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0735-1097(99)00525-2","volume":"35","author":"CJ Vaughan","year":"2000","unstructured":"Vaughan CJ, Gotto AM, Basson CT: The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol 2000, 35:1\u201310.","journal-title":"J Am Coll Cardiol"},{"key":"23_CR38","doi-asserted-by":"crossref","unstructured":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in high risk individuals. A randomized placebo controlled trial [no authors listed]. Lancet 2003, 36:7\u201322.","DOI":"10.1016\/S0140-6736(02)09327-3"},{"key":"23_CR39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","volume":"110","author":"SM Grundy","year":"2004","unstructured":"Grundy SM, Cleeman JI, Merz CN, et al.: Implications of recent clinical trials for the National Cholesterol Education Program. Adult Treatment Panel III Guidelines. Circulation 2004, 110:227\u2013239.","journal-title":"Circulation"},{"key":"23_CR40","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJM199908053410604","volume":"341","author":"HB Rubins","year":"1999","unstructured":"Rubins HB, Robins S, Collins D, et al.: Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. N Eng J Med 1999, 341:410\u2013418.","journal-title":"N Eng J Med"},{"key":"23_CR41","doi-asserted-by":"crossref","unstructured":"Seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure (JNCVII) [no authors listed]. Hypertension 2004, 43:1\u20133.","DOI":"10.1161\/01.HYP.0000110061.06674.ca"},{"key":"23_CR42","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","volume":"288","author":"ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group","year":"2002","unstructured":"ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: Major outcomes in high risk hypertensive patients. Randomized angiotensin-converting enzyme inhibitor, calcium channel blocker vs. diuretic. The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002, 288:2981\u20132987.","journal-title":"JAMA"},{"key":"23_CR43","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1161\/01.CIR.0000142664.18739.92","volume":"110","author":"E Zouridakis","year":"2004","unstructured":"Zouridakis E, Avanzas P, Arroyo-Espliguero R, et al.: Markers of inflammation and rapid coronary progression in patients with stable angina pectoris. Circulation 2004, 110:1747\u20131753. A recent review of the relationship between inflammatory markers and progression of disease in patients with stable angina.","journal-title":"Circulation"},{"key":"23_CR44","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1161\/01.CIR.96.7.2162","volume":"96","author":"BR Chaitman","year":"1997","unstructured":"Chaitman BR, Rosen AD, Williams DO, et al.: Myocardial infarction and cardiac mortality in the bypass angioplasty revascularization investigation (BARI) randomized trial. Circulation 1997, 96:2162\u20132170.","journal-title":"Circulation"},{"key":"23_CR45","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0735-1097(03)00951-3","volume":"42","author":"RA Henderson","year":"2003","unstructured":"Henderson RA, Pocock SJ, Clayton TC, et al.: Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy. J Am Coll Cardiol 2003, 42:1167\u20131170. A well-designed large randomized trial comparing medical treatment to coronary angioplasty.","journal-title":"J Am Coll Cardiol"},{"key":"23_CR46","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1161\/01.CIR.0000113457.41084.82","volume":"109","author":"DP Faxon","year":"2004","unstructured":"Faxon DP: Bringing reality to drug-coated stents. Circulation 2004, 109:140\u2013142. An important editorial that cautions against the widespread use of stents in CAD.","journal-title":"Circulation"},{"key":"23_CR47","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM199907083410202","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Waters D, Brown WV, et al.: Aggressive lipidlowering therapy compared with angioplasty in stable coronary artery disease. N Engl J Med 1999, 341:70\u201376.","journal-title":"N Engl J Med"},{"key":"23_CR48","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/01.CIR.0000121360.31954.1F","volume":"109","author":"R Hambrecht","year":"2004","unstructured":"HambrechtR, Walther C, Mobius-Winkler S, et al.: Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease. Circulation 2004, 109:1371\u20131378. A small but provocative trial showing that exercise training is superior compared with coronary angioplasty in patients with stable CAD.","journal-title":"Circulation"},{"key":"23_CR49","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.cir.0000087941.75337.f5","volume":"108","author":"C Muneretto","year":"2003","unstructured":"Muneretto C, Bisleri G, Negri A, et al.: Total arterial myocardial revascularization with composite grafts improves results of coronary surgery in elderly: a prospective randomized comparison with conventional coronary artery bypass surgery. Circulation 2003, 108:1129\u20131133.","journal-title":"Circulation"},{"key":"23_CR50","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0735-1097(02)01716-3","volume":"39","author":"MC Kim","year":"2002","unstructured":"Kim MC, Kini A, Sharma SK: Refractory angina pectoris. J Am Coll Cardiol 2002, 39:923\u2013934. A good review article highlighting the problems of managing patients with refractory angina.","journal-title":"J Am Coll Cardiol"},{"key":"23_CR51","first-page":"535","volume-title":"Acute Coronary Syndromes: A Companion to Braunwald\u2019s Heart Disease.","author":"U Thadani","year":"2003","unstructured":"Thadani U: Patient with disabling angina not amenable to revascularization procedures. In Acute Coronary Syndromes: A Companion to Braunwald\u2019s Heart Disease. Edited by Theroux P. Philadelpha, PA: WB Saunders; 2003:535\u2013552. An in-depth article on current usefulness and limitations of pharmacotherapy, invasive therapy, and devices in the management of patients with refractory angina."},{"issue":"suppl 1","key":"23_CR52","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/01.mca.0000129883.86374.6c","volume":"15","author":"U Thadani","year":"2004","unstructured":"Thadani U: Recurrent and refractory angina following revascularization procedures in patients with stable angina [editorial]. Coron Artery Dis 2004, 15(suppl 1):S1-S4.","journal-title":"Coron Artery Dis"},{"key":"23_CR53","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/clc.4960230406","volume":"23","author":"WE Lawson","year":"2000","unstructured":"Lawson WE, Hui JC, Cohn PF: Long-term prognosis of patients with angina treatment with enhanced external counterpulsation: five-year follow-up study. Clin Cardiol 2000, 23:254\u2013258.","journal-title":"Clin Cardiol"},{"key":"23_CR54","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/clc.4960240604","volume":"24","author":"G Barsness","year":"2001","unstructured":"Barsness G, Feldman AM, Holmes DR, et al.: The International EECP Patient Registry (IEPR): design, methods, baseline characteristics, and acute results. Clin Cardiol 2001, 24:435\u2013442.","journal-title":"Clin Cardiol"},{"issue":"suppl 1","key":"23_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/hc37t1.094774","volume":"104","author":"KA Horvath","year":"2001","unstructured":"Horvath KA, Aranki SF, Cohn LH, et al.: Sustained angina relief 5 years after transmyocardial laser revascularization with a CO2 laser. Circulation 2001, 104(suppl 1):1\u20134.","journal-title":"Circulation"},{"key":"23_CR56","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/01.CIR.97.12.1157","volume":"37","author":"C Mannheimer","year":"1998","unstructured":"Mannheimer C, Eliasson T, Augustinsson LE, et al.: Electrical stimulation versus coronary artery bypass surgery is severe angina pectoris: the ESBY study. Circulation 1998, 37:1157\u20131163.","journal-title":"Circulation"},{"key":"23_CR57","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1056\/NEJMoa042739","volume":"351","author":"E Braunwald","year":"2004","unstructured":"BraunwaldE, Domanski MJ, Fowler SE, et al.: Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Eng J Med 2004, 351:2058\u20132068. A large long-term trial that shows that ACE inhibitor did not reduce adverse clinical outcomes compared with placebo in patients with documented CAD and preserved LV function.","journal-title":"N Eng J Med"}],"container-title":["Current Treatment Options in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-006-0023-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11936-006-0023-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-006-0023-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:52:33Z","timestamp":1559436753000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11936-006-0023-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["23"],"URL":"https:\/\/doi.org\/10.1007\/s11936-006-0023-9","relation":{},"ISSN":["1092-8464","1534-3189"],"issn-type":[{"value":"1092-8464","type":"print"},{"value":"1534-3189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}